The seismic modifications made by the present administration in america proceed to affect the scientific group. The enterprise information section of this week’s episode covers the results of job cuts on biotech, Roche’s manufacturing and R&D plans amid tariff threats, and shares an replace on Eli Lilly’s diabetes tablet. Additionally, in honor of DNA Day, we reminisce about how far the sphere has come because the discovery of the construction of DNA and the completion of the Human Genome Mission. We additionally speak about in the present day’s DNA-related advances that use machine studying to design tailor-made Cas9 proteins, and a number of sequencing applied sciences to review mutation charges in 4 generations of the identical household.
Listed under are hyperlinks to the GEN tales referenced on this episode of Touching Base:
After Job Cuts, “We’re Getting into a Very New Territory for BiotechBy Alex Philippidis, GEN Edge, April 17, 2025
Roche Commits $50B to U.S. Manufacturing, R&D as Tariffs LoomBy Alex Philippidis, GEN Edge, April 22, 2025
StockWatch: Buyers Hungry for Lilly after Diabetes Tablet Aces Section III TrialBy Alex Philippidis, GEN Edge, April 20, 2025
Machine Studying Engineers Bespoke Cas9 Enzymes for Gene ModifyingBy Fay Lin, PhD, GEN, April 22, 2025
Multi-Platform Sequencing Examine of 4 Generations Sheds Gentle on Mutation ChargesGEN, April 23, 2025
Produced with assist from:
